Effects of Neiyanggong on cancer-related fatigue in breast cancer patients undergoing chemotherapy: a randomized controlled trial
Supportive Care in Cancer · 2026-08 · 34 (8)
DOI: 10.1007/s00520-026-11029-7 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Supportive Care in Cancer, online erschienen am 24.07.2026. Verfasst von Yaci Du und 6 weiteren Autor:innen. Beteiligte Einrichtung: North China University of Science and Technology, Tangshan, 063210, China. Hauptthemen laut MEDLINE: Breast Neoplasms, Fatigue, Antineoplastic Agents. Die Arbeit nennt 33 Literaturangaben.
Themen: Onkologische Pflege
Abstract (Originalsprache)
PURPOSE: This study aimed to develop a dynamic-static combined Neiyanggong intervention for breast cancer patients undergoing chemotherapy and to evaluate its effectiveness in alleviating cancer-related fatigue, with sleep quality assessed as a secondary outcome. METHODS: A single-center, parallel-group randomized controlled trial was conducted. Seventy-two patients receiving chemotherapy were randomly allocated (1:1) to a Neiyanggong group (n = 36) or a control group (n = 36). The control group received routine treatment and nursing care. The Neiyanggong group additionally practiced a staged progressive dynamic-static Neiyanggong program based on disease-specific characteristics across three chemotherapy cycles. The Piper fatigue scale-revised (PFS-R) and Pittsburgh sleep quality index (PSQI) were assessed at baseline and after each chemotherapy cycle. RESULTS: A significant interaction effect was found for the PFS-R total score (F = 94.810, P < 0.001, η2 = 0.807), indicating a progressive reduction in fatigue over time in the Neiyanggong group. After the third cycle, fatigue scores were significantly lower in the Neiyanggong group compared with the control group (P < 0.05). For the PSQI total score, significant group effects (Wald χ2 = 31.352, P < 0.001), time effects (Wald χ2 = 105.524, P < 0.001), and interaction effects (Wald χ2 = 292.975, P < 0.001) were identified. The Neiyanggong group showed the most notable improvements in sleep latency, sleep efficiency, and daytime dysfunction (P < 0.001). No adverse events occurred, and adherence was high. CONCLUSION: The findings suggest that the staged progressive dynamic-static combined Neiyanggong intervention is a promising non-pharmacological approach that can effectively reduce cancer-related fatigue and improve sleep quality.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- North China University of Science and Technology, Tangshan, 063210, China.
- Tianjin Union Medical Center, The First Affiliated Hospital of Nankai University, Nankai University, Tianjin, 300121, China.
- North China University of Science and Technology, Tangshan, 063210, China. 723375698@qq.com.
- North China University of Science and Technology Affiliated Hospital, Tangshan, 063210, China. zhangweijia1111@163.com.
- North China University of Science and Technology Affiliated Hospital, Tangshan, 063210, China.
Zitieren
APA
Du, Y., Wang, J., Zhang, C., Guo, Q., Hao, X., Zhang, W., & Jiao, G. (2026). Effects of Neiyanggong on cancer-related fatigue in breast cancer patients undergoing chemotherapy: a randomized controlled trial. Supportive Care in Cancer, 34(8). https://doi.org/10.1007/s00520-026-11029-7
Vancouver
Du Y, Wang J, Zhang C, Guo Q, Hao X, Zhang W, et al. Effects of Neiyanggong on cancer-related fatigue in breast cancer patients undergoing chemotherapy: a randomized controlled trial. Supportive Care in Cancer. 2026;34(8). doi:10.1007/s00520-026-11029-7
BibTeX
@article{Du2026,
author = {Du, Yaci and Wang, Jing and Zhang, Cui and Guo, Quanrong and Hao, Xijun and Zhang, Weijia and Jiao, Guimei},
title = {Effects of Neiyanggong on cancer-related fatigue in breast cancer patients undergoing chemotherapy: a randomized controlled trial},
journal = {Supportive Care in Cancer},
year = {2026},
volume = {34},
number = {8},
doi = {10.1007/s00520-026-11029-7}
}
EUVIMED